HROW
Price
$32.67
Change
-$1.86 (-5.39%)
Updated
Jul 30, 04:59 PM (EDT)
Capitalization
467.85M
12 days until earnings call
LFCR
Price
$7.10
Change
-$0.12 (-1.66%)
Updated
Jul 30, 04:59 PM (EDT)
Capitalization
176.87M
27 days until earnings call
Interact to see
Advertisement

HROW vs LFCR

Header iconHROW vs LFCR Comparison
Open Charts HROW vs LFCRBanner chart's image
Harrow
Price$32.67
Change-$1.86 (-5.39%)
Volume$6.63K
Capitalization467.85M
Lifecore Biomedical
Price$7.10
Change-$0.12 (-1.66%)
Volume$800
Capitalization176.87M
HROW vs LFCR Comparison Chart in %
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. LFCR commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a StrongBuy and LFCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (HROW: $32.69 vs. LFCR: $7.11)
Brand notoriety: HROW and LFCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HROW: 106% vs. LFCR: 34%
Market capitalization -- HROW: $467.85M vs. LFCR: $176.87M
HROW [@Pharmaceuticals: Other] is valued at $467.85M. LFCR’s [@Pharmaceuticals: Other] market capitalization is $176.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, HROW is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 3 TA indicator(s) are bullish while LFCR’s TA Score has 3 bullish TA indicator(s).

  • HROW’s TA Score: 3 bullish, 5 bearish.
  • LFCR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both HROW and LFCR are a bad buy in the short-term.

Price Growth

HROW (@Pharmaceuticals: Other) experienced а -11.53% price change this week, while LFCR (@Pharmaceuticals: Other) price change was -5.58% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.65%. For the same industry, the average monthly price growth was +7.55%, and the average quarterly price growth was +88.74%.

Reported Earning Dates

HROW is expected to report earnings on Nov 17, 2025.

LFCR is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.65% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($468M) has a higher market cap than LFCR($177M). HROW YTD gains are higher at: -2.563 vs. LFCR (-4.307). HROW has higher annual earnings (EBITDA): 9.95M vs. LFCR (-22.64M). HROW has more cash in the bank: 82.8M vs. LFCR (4.22M). LFCR has less debt than HROW: LFCR (157M) vs HROW (191M). LFCR has higher revenues than HROW: LFCR (188M) vs HROW (130M).
HROWLFCRHROW / LFCR
Capitalization468M177M264%
EBITDA9.95M-22.64M-44%
Gain YTD-2.563-4.30760%
P/E Ratio39.53N/A-
Revenue130M188M69%
Total Cash82.8M4.22M1,961%
Total Debt191M157M122%
FUNDAMENTALS RATINGS
HROW vs LFCR: Fundamental Ratings
HROW
LFCR
OUTLOOK RATING
1..100
6652
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4152
P/E GROWTH RATING
1..100
105
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HROW's Valuation (78) in the Pharmaceuticals Other industry is in the same range as LFCR (94) in the Industrial Specialties industry. This means that HROW’s stock grew similarly to LFCR’s over the last 12 months.

HROW's Profit vs Risk Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that HROW’s stock grew somewhat faster than LFCR’s over the last 12 months.

HROW's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that HROW’s stock grew similarly to LFCR’s over the last 12 months.

HROW's Price Growth Rating (41) in the Pharmaceuticals Other industry is in the same range as LFCR (52) in the Industrial Specialties industry. This means that HROW’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is in the same range as HROW (10) in the Pharmaceuticals Other industry. This means that LFCR’s stock grew similarly to HROW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWLFCR
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WVMDF0.970.01
+1.52%
West Vault Mining Inc.
KWHIF70.79N/A
N/A
Kawasaki Heavy Industries Ltd.
OCPNF12.10N/A
N/A
Olympus Corp.
TTGXF0.04N/A
N/A
Trans Canada Gold Corp.
SVCTF250.02N/A
N/A
Senvest Capital Inc.

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-5.33%
AMRX - HROW
46%
Loosely correlated
-0.25%
EBS - HROW
38%
Loosely correlated
-6.62%
OGI - HROW
33%
Loosely correlated
-2.84%
VTRS - HROW
32%
Poorly correlated
-2.07%
AMPH - HROW
31%
Poorly correlated
-1.52%
More

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.52%
SHPH - LFCR
31%
Poorly correlated
-2.62%
AMRX - LFCR
27%
Poorly correlated
-0.25%
TLRY - LFCR
27%
Poorly correlated
+6.15%
ALKS - LFCR
26%
Poorly correlated
+3.44%
HROW - LFCR
26%
Poorly correlated
-5.33%
More